A panel of experts discuss the role of genetics in Alzheimer's disease, including how genetics is influencing diagnosis and research today. March 14, 2012 Moderated by WCBS-TV Medical Reporter, Dr. Max Gomez Event Participants Lou-Ellen Barkan, President & CEO, Alzheimer's Association, New York City Chapter Jed Levine, M.A., Executive Vice President, Director of Programs and Services, Alzheimer's Association, New York City Chapter Richard Mayeux, M.D., M.S., Chairman, Department of Neurology and Co-Director, Taub Institute of Research on Alzheimer's Disease and the Aging Brain, Columbia University Roy Twyman, M.D., Head of Development, CNS, Neuroscience Therapeutic Area, Janssen Research & Development, LLC Jennifer Williamson, M.S., M.P.H., Genetic Counselor, Taub Institute of Research on Alzheimer's Disease and the Aging Brain, Columbia University This program was developed by the Alzheimer's Association, New York City Chapter, Janssen Alzheimer Immunotherapy Research & Development, LLC, Janssen Pharmaceuticals, Inc., and Janssen Research & Development, LLC, with funding from the Janssen companies. This event is for the general public and is not certified for continuing medical education for healthcare professionals.

Be the first to comment